For instance, the PDE10A inhibitor, papaverine, was found to suppress conditioned avoidance responses in rats, suggesting potential therapeutic roles in schizophrenia and in Alzhemier’s disease [10]. The gene discussed is PDE10A; the disease is schizophrenia.